Recent Developments:
# In 2017, Swiss Precision Diagnostics (Switzerland) launched its Clearblue Connected Ovulation Test System.
# In 2017, NFI Consumer Healthcare (US) a division of Gregory Pharmaceutical Holdings (US) completed the acquisition of e.p.t over-the-counter pregnancy test kit brand from Prestige Brands Holdings.
# In 2017, Fairhaven Health (US), launched TempCue, a basal body temperature (BBT) thermometer.
# In 2016, Fertility Focus (UK) launched OvuSense App.
Global Growth Boosters:
The major factors driving the growth of the fertility test market include declining fertility rates across the globe, increasing first-time pregnancy age, introduction of advanced, user-friendly fertility monitors with high accuracy.
Key Questions Addressed by the Report:
# What are the growth opportunities related to the adoption of fertility test products across major regions in the future?
# Emerging countries have immense opportunities for the growth and adoption of ovulation prediction kits. Will this scenario continue in the next five years?
# Where will all the advancements in products offered by various companies take the industry in the mid- to long-term?
# How will the increasing use of ovulation tracking mobile apps and fertility-tracking websites affect the growth of the market?
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=139945432
North America is expected to dominate the fertility test market during the forecast period.
Geographically, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to account for the largest share of the global fertility test market during the forecast period (2018-2023). The large share can be attributed to the growing use of fertility monitoring devices for contraception and rising awareness about the benefits of ovulation monitors through social media, marketing campaigns, and e-commerce sites. In addition, the emergence of advanced easy-to-use fertility monitors with high accuracy is one of the key factors propelling the growth of the fertility test market in North America.
By end user, the home care settings segment is expected to account for the largest share during the forecast period.
The fertility test market, by end user, is segmented into home care settings and hospitals, fertility clinics, and others. In 2018, the home care settings segment is expected to account for the largest share of the fertility test market. The large share can be attributed to the decline of fertility rates in women and men, increasing need for continuous monitoring of health conditions, and growing preference for home and remote monitoring.
Global Leaders:
The major players operating in the fertility test market include SPD Swiss Precision Diagnostics (Switzerland), Church & Dwight (US), and Prestige Brands Holdings (US), among others.
Analysis of the market developments between 2015 and 2018 revealed that several growth strategies such as product launches, enhancements, and strategic acquisitions were adopted by the market players to strengthen their product portfolios and maintain a competitive position in the fertility test market. Among these business strategies, product launches was the most widely adopted growth strategies by the players in the fertility test market.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=139945432
